Skip to main content
. 2018 Mar 28;6(1):11–15. doi: 10.2478/jtim-2018-0003

Table 1.

TIPS treatment for portal vein thrombosis in patients with cirrhosis

Author, year, (Ref.) Number of patients, study design Age of thrombosis Grade of PVT partial/occlusive/cavernoma** (n) Resolution of PVT partial/complete/any (%)
Van Ha, 2006[22] 15, retrospective Acute 11 Chronic 4 7/8/4 n.d.∗/n.d.*/77
Bauer, 2006[23] 9, retrospective Chronic 9 0/9/4 11/56/67
Senzolo, 2006[11] 13, retrospective 5.5 months (0.5–24) 5/8/3 n.d.*
Perarnau, 2010[24] 123, retrospective Acute 15 Chronic 108 94/29/14 n.d.*
Han, 2011[25] 57, retrospective Acute 0 Chronic 57 35/22/30 n.d.*/n.d.*/100***
Luca, 2011[10] 70, prospective 4.7 months (0–66) 46/24/2 30/57/87
Senzolo, 2012[13] 7, prospective n.d.* n.d.* 67/33/100***
Avola, 2012[20] 15, retrospective Chronic 15 15/0/0 0/100/100
Salem, 2015[12] 44, retrospective Chronic 44 0/44/13 16/74/90
Luo, 2015[26]§ 37, prospective Chronic 37 24/13/0 13/52/65
Zhao, 2016[27] 191, retrospective n.d.* 143/48/? 31/69/100***
Lv, 2017[28] 212, retrospective Acute 17 Chronic 195 150/62/47 n.d.*
Lv, 2017[29] § 24, randomized Acute 2 Chronic 22 16/8/11 9/86/95
**

Patients with a cavernoma are a subgroup of patients with occlusive thrombosis;

*

n.d.: no sufficient data;

***

Only for patients with successful TIPS intervention;

§

randomized study, TIPS versus medical treatment (banding ligation and propranolol). All patients received Vit K antagonists. TIPS: transjugular intrahepatic portosystemic shunt; PVT: portal vein thrombosis.